Intradermal Injection of Anti-CTLA-4 in Patients With Stage I/II Melanoma

Condition:   Cutaneous Melanoma Intervention:   Drug: Tremelimumab Sponsor:   A.J.M. van den Eertwegh Completed

Source: ClinicalTrials.gov - February 18, 2020 Category: Research Source Type: clinical trials